ACMA
TMO icon

Arbor Capital Management (Alaska)’s Thermo Fisher Scientific TMO Stock Holding History

Arbor Capital Management (Alaska)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$997K Buy
1,947
+15
+0.8% +$8.14K 0.81% 51
2025
Q4 		$1.16M Sell
1,932
-229
-11% -$130K 0.98% 47
2025
Q3 		$1.1M Sell
2,161
-385
-15% -$179K 0.89% 49
2025
Q2 		$1.14M Buy
2,546
+606
+31% +$253K 1% 44
2025
Q1 		$948K Buy
1,940
+151
+8% +$81.8K 0.92% 48
2024
Q4 		$1.02M Sell
1,789
-34
-2% -$18.7K 1% 45
2024
Q3 		$1.12M Sell
1,823
-5
-0.3% -$2.96K 1.06% 45
2024
Q2 		$990K Sell
1,828
-106
-5% -$60.7K 0.91% 47
2024
Q1 		$1.11M Sell
1,934
-178
-8% -$99.9K 1.05% 47
2023
Q4 		$1.12M Buy
2,112
+59
+3% +$28.6K 0.84% 58
2023
Q3 		$958K Buy
2,053
+157
+8% +$83.7K 0.85% 56
2023
Q2 		$981K Buy
1,896
+188
+11% +$101K 0.76% 60
2023
Q1 		$981K Sell
1,708
-75
-4% -$42.3K 0.8% 57
2022
Q4 		$987K Sell
1,783
-154
-8% -$81.6K 0.88% 54
2022
Q3 		$1.04M Buy
1,937
+79
+4% +$44.2K 0.94% 49
2022
Q2 		$1.01M Sell
1,858
-26
-1% -$14.3K 0.96% 53
2022
Q1 		$1.11M Sell
1,884
-737
-28% -$423K 0.85% 59
2021
Q4 		$1.75M Buy
+2,621
New +$1.64M 1.24% 36

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arbor Capital Management (Alaska)'s TMO Position: Q1 2026 in Review

Arbor Capital Management (Alaska) increased its Thermo Fisher Scientific (TMO) stake by 0.78% in Q1 2026, buying an estimated $8.14K and bringing the position to 1,947 shares worth $997K. The position accounts for 0.81% of the portfolio, ranked #51.

Arbor Capital Management (Alaska) first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.75M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Arbor Capital Management (Alaska) held 1,947 shares of Thermo Fisher Scientific worth $997K as of Q1 2026.
  • Arbor Capital Management (Alaska) bought 15 Thermo Fisher Scientific shares in Q1 2026, an estimated $8.14K.
  • Thermo Fisher Scientific made up 0.81% of Arbor Capital Management (Alaska)'s portfolio in Q1 2026, its #51 holding.
  • Arbor Capital Management (Alaska) first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • Arbor Capital Management (Alaska)'s Thermo Fisher Scientific position peaked at $1.75M in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Arbor Capital Management (Alaska)'s 13F filing for Q1 2026, filed 30 Apr 2026.